ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.62
0.53%
US Dollar vs AUD
1.52966
-0.22%
Bitcoin
64,290.87
-0.30%
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avenue Therapeutics Inc (ATXI)

  7. Avenue Therapeutics Inc (ATXI) News

ATXI Avenue Therapeutics Inc

8.775
0.00 (0.00%)
Pre Market
Last Updated: 21:35:39
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Avenue Therapeutics Inc ATXI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 8.775 21:35:39
Open Price Low Price High Price Close Price Previous Close
8.775
more quote information »

Recent News

Date Time Source Heading
24/4/202421:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
25/3/202423:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
19/3/202407:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
15/3/202423:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
11/3/202423:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
09/3/202408:31EDGAR2Form PRE 14C - Other preliminary information statements
09/3/202408:15EDGAR2Form 8-K - Current report
23/2/202400:30GLOBEAvenue Therapeutics Announces Publication in Drug..
02/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
30/1/202400:00EDGAR2Form DEF 14C - Other definitive information statements
25/1/202408:11EDGAR2Form S-3 - Registration statement under Securities Act of..
18/1/202409:05EDGAR2Form PRE 14C - Other preliminary information statements
12/1/202422:01EDGAR2Form 8-K - Current report
12/1/202400:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
09/1/202409:28EDGAR2Form 8-K - Current report
06/1/202401:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
05/1/202400:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
03/1/202400:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
14/12/202308:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/12/202308:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202300:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
29/11/202308:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/11/202308:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/11/202305:19EDGAR2Form 8-K - Current report
14/11/202308:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:10EDGAR2Form 8-K - Current report
14/11/202308:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
03/11/202307:10EDGAR2Form 8-K - Current report
03/11/202306:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
03/11/202300:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
01/11/202300:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
06/10/202308:05EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
30/9/202307:23EDGAR2Form S-1/A - General form for registration of securities..
29/9/202306:25EDGAR2Form 8-K - Current report
28/9/202306:03EDGAR2Form 8-K - Current report
19/9/202307:18EDGAR2Form S-1 - General form for registration of securities under..
09/9/202306:15EDGAR2Form 8-K - Current report
05/9/202322:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
15/8/202306:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
12/8/202306:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:20EDGAR2Form 8-K - Current report
11/8/202306:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
01/8/202322:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..
27/7/202322:30GLOBEAvenue Therapeutics Announces First Patient Dosed in Phase..
25/7/202322:30GLOBEAvenue Therapeutics Announces Agreement with the FDA on the..
22/7/202306:37EDGAR2Form 8-K - Current report
06/7/202306:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202306:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202306:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/7/202303:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
ATXI
Avenue Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved